S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
NYSE:ENZ

Enzo Biochem (ENZ) Stock Price, News & Analysis

$1.26
+0.01 (+0.80%)
(As of 03/27/2024 ET)
Today's Range
$1.23
$1.30
50-Day Range
$1.22
$1.39
52-Week Range
$1.16
$2.74
Volume
87,046 shs
Average Volume
94,875 shs
Market Capitalization
$64.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ENZ stock logo

About Enzo Biochem Stock (NYSE:ENZ)

Enzo Biochem, Inc. develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. It also provides AMPIVIEW in situ hybridization probes for enhanced detection of low expressed targets useful in the growing spatial biology space; reagents and assays for cell and gene therapy research and development; POLYVIEW PLUS Enhanced Immunohistochemistry platform, offers solutions within the area of anatomical pathology through optimized assays; Enhanced Immunoassays, pushing sensitivity to expand immunoassay applications for basic research, bioprocess, and diagnostics; AMPIPROBE, a nucleic acid amplification platform; and Axxora.com, a proven distribution platform for original manufacturers of innovative research reagents. The company's proprietary products and technologies in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. It markets its products and services through its direct sales force and a network of distributors. The company was incorporated in 1976 and is headquartered in Farmingdale, New York.

ENZ Stock Price History

ENZ Stock News Headlines

Short Interest in Enzo Biochem, Inc. (NYSE:ENZ) Drops By 9.8%
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Enzo Biochem: Fiscal Q2 Earnings Snapshot
Enzo Biochem, Inc.
Jim Simons Trims Stake in Enzo Biochem Inc
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Enzo Biochem Appoints New CEO and CFO
Enzo Biochem Inc (EZB.SG)
Enzo Biochem Inc ENZ
Enzo Biochem CEO Hamid Erfanian Resigns After Two Years
See More Headlines
Receive ENZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enzo Biochem and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/15/2019
Today
3/27/2024
Next Earnings (Estimated)
6/12/2024
Fiscal Year End
7/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical laboratories
Sub-Industry
N/A
Employees
179
Year Founded
1976

Profitability

Net Income
$20.29 million
Pretax Margin
-71.07%

Debt

Sales & Book Value

Annual Sales
$31.06 million
Book Value
$1.38 per share

Miscellaneous

Free Float
43,286,000
Market Cap
$64.55 million
Optionable
Optionable
Beta
0.75

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

ENZ Stock Analysis - Frequently Asked Questions

How have ENZ shares performed in 2024?

Enzo Biochem's stock was trading at $1.39 at the beginning of the year. Since then, ENZ shares have decreased by 9.4% and is now trading at $1.26.
View the best growth stocks for 2024 here
.

Are investors shorting Enzo Biochem?

Enzo Biochem saw a decline in short interest during the month of February. As of February 29th, there was short interest totaling 715,400 shares, a decline of 9.8% from the February 14th total of 792,900 shares. Based on an average daily volume of 113,500 shares, the short-interest ratio is presently 6.3 days. Currently, 2.1% of the shares of the stock are short sold.
View Enzo Biochem's Short Interest
.

When is Enzo Biochem's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, June 12th 2024.
View our ENZ earnings forecast
.

How were Enzo Biochem's earnings last quarter?

Enzo Biochem, Inc. (NYSE:ENZ) released its quarterly earnings data on Tuesday, October, 15th. The medical research company reported ($0.11) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.14) by $0.03. The medical research company earned $20.92 million during the quarter. Enzo Biochem had a net margin of 99.28% and a negative trailing twelve-month return on equity of 36.71%.

What other stocks do shareholders of Enzo Biochem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Enzo Biochem investors own include OneLife Technologies (OLMM), Gilead Sciences (GILD), OPKO Health (OPK), Teva Pharmaceutical Industries (TEVA), Inovio Pharmaceuticals (INO), AbbVie (ABBV), Pfizer (PFE), Advanced Micro Devices (AMD), Amarin (AMRN) and Micron Technology (MU).

Who are Enzo Biochem's major shareholders?

Enzo Biochem's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (3.72%), Vanguard Group Inc. (3.72%), Potomac Capital Management Inc. (2.93%), Dimensional Fund Advisors LP (1.45%), Northern Trust Corp (0.22%) and FNY Investment Advisers LLC (0.15%). Insiders that own company stock include Bradley Louis Radoff, David Bench, Hamid Erfanian, James G Wolf and Kara Cannon.
View institutional ownership trends
.

How do I buy shares of Enzo Biochem?

Shares of ENZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:ENZ) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners